Abstract
Objectivesto evaluate the effects of tofacitinib (TOFA) on cardiovascular risk factors (CVRF) in rheumatoid arthritis (RA) patients (pts).MethodsAfter 12-m follow-up the CVRF dynamic was assessed in 28 RA pts treated...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
